Potential use of 109Pd-porphyrin complexes for selective lymphatic ablation.
D000818:Animals; D000917:Antibody Formation; D001853:Bone Marrow / Q000528:radiation effects; D004285:Dogs; D006084:Graft Rejection; D007108:Immune Tolerance; D007275:Injections, Intravenous; D007413:Intestinal Mucosa / Q000528:radiation effects; D008198:Lymph Nodes / Q000528:radiation effects; D008221:Lymphoid Tissue / Q000276:immunology / Q000528:radiation effects*; D010165:Palladium / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D011817:Rabbits; D011830:Radiation Effects; D011868:Radioisotopes / Q000627:therapeutic use*; D013154:Spleen / Q000528:radiation effects; D013950:Thymus Gland / Q000528:radiation effects; D014181:Transplantation Immunology
D011166:Porphyrins; D011868:Radioisotopes; D010165:Palladium